USPTO Patent Grant for Physiological Monitoring System

The United States Patent and Trademark Office (USPTO) has issued a patent (US12582313B2) to Masimo Corporation for a physiological monitoring system. This patent, effective March 24, 2026, details a method and system for conducting advanced signal processing on patient physiological data collected by a sensor and transmitted via a mobile computing device.

This patent grant represents a new intellectual property asset for Masimo Corporation in the field of medical devices and patient monitoring. While not imposing direct regulatory obligations on other entities, it signifies innovation in diagnostic and surgical technology. Compliance officers in the medical device sector should be aware of this patent as it pertains to the technological landscape and potential intellectual property considerations for similar monitoring systems.